Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Bausch Health Companies Inc (BHC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bausch Health's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.66 -0.07    -0.86%
17/04 - Closed. Currency in USD ( Disclaimer )
After Hours
8.61
-0.05
-0.58%
19:39:38 - Real-time Data
  • Volume: 2,156,489
  • Bid/Ask: 8.55 / 8.89
  • Day's Range: 8.65 - 8.93
Type:  Equity
Market:  United States
Bausch Health 8.66 -0.07 -0.86%

BHC Financial Summary

 
A brief financial summary of Bausch Health Companies Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Bausch Health Companies Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 2,408 million compared to USD 2,193 million a year ago. Net loss was USD 39 million compared to USD 410 million a year ago.For the full year, revenue was USD 8,757 million compared to USD 8,124 million a year ago. Net loss was USD 592 million compared to USD 225 million a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BHC Income Statement

Gross margin TTM 70.78%
Operating margin TTM 18.51%
Net Profit margin TTM -6.76%
Return on Investment TTM 0%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 2408 2238 2167 1944
Gross Profit 1703 1615 1518 1362
Operating Income 507 494 381 227
Net Income -39 -378 26 -201

BHC Balance Sheet

Quick Ratio MRQ 0.68
Current Ratio MRQ 1.3
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -2,211.06%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 27350 27064 25503 25445
Total Liabilities 27432 27299 25232 25300
Total Equity -82 -235 271 145

BHC Cash Flow Statement

Cash Flow/Share TTM 2.83
Revenue/Share TTM 23.98
Operating Cash Flow  9.07%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 390 282 206 154
Cash From Investing Activities -148 -1889 -30 -78
Cash From Financing Activities -79 1816 -120 -142
Net Change in Cash 182 192 57 -60
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BHC Comments

Write your thoughts about Bausch Health Companies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mohammad Ali
Mohammad Ali Mar 27, 2024 14:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
depends on quarterly results
David Harrison
David Harrison Mar 02, 2021 15:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bullish
Cody Tilma
Cody Tilma Feb 26, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will look at this again at around $25, bearish till then
Peter Petrossi
Peter Petrossi Feb 19, 2020 11:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sorry...who wrote the next comment.
Peter Petrossi
Peter Petrossi Jul 11, 2019 13:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sing it! dreaming..... only dreaming. at what point do analyst get banned for 'fake' analysis?
Srinath Gunaratne
Srinath Gunaratne Aug 14, 2016 0:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
Mohammed Ali
Mohammed Ali Jul 07, 2016 23:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
Jeremiah Cox
Jeremiah Cox Jul 07, 2016 23:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
PAKAWA pakawa
PAKAWA pakawa Jul 07, 2016 23:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jeremiah Cox  . re: "have a feeling", never be emotional about the markets.......it'd hurt you
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email